Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) in Healthy Pregnant Women
- First Posted Date
- 2025-05-30
- Last Posted Date
- 2025-05-30
- Lead Sponsor
- Health Institutes of Turkey
- Registration Number
- NCT06997653
- Locations
- 🇹🇷
T.R. Ministry of Health Ankara City Hospital, Gynecology and Obstetrics Hospital, Ankara, Turkey
Observational National Vaccine Study
- Conditions
- COVID-19 Infection
- Interventions
- Biological: Taking biological samples (blood) and keeping records with phone calls
- First Posted Date
- 2023-05-18
- Last Posted Date
- 2024-05-24
- Lead Sponsor
- Health Institutes of Turkey
- Target Recruit Count
- 200
- Registration Number
- NCT05863429
- Locations
- 🇹🇷
Ankara City Hospital Internal Medicine Clinic, Ankara, Turkey
🇹🇷T.R. Ministry of Health Abant Izzet Baysal University Training and Research Hospital, Bolu, Turkey
🇹🇷Eskişehir City Hospital Internal Medicine, Eskişehir, Turkey
Efficacy, Immunogenicity, and Safety of TURKOVAC Vaccine Versus the CoronaVac Vaccine Against COVID-19 in Healthy Adolescent
- Conditions
- COVID-19Sars-CoV-2 Infection
- Interventions
- Biological: TURKOVACBiological: CoronaVac
- First Posted Date
- 2022-02-09
- Last Posted Date
- 2024-05-28
- Lead Sponsor
- Health Institutes of Turkey
- Target Recruit Count
- 1
- Registration Number
- NCT05230940
- Locations
- 🇹🇷
Health Sciences University Adana City Training and Research Hospital, Pediatric Health and Diseases, Adana, Turkey
🇹🇷Çukurova University Faculty of Medicine Department of Pediatric Infectious Diseases, Adana, Turkey
🇹🇷T.R. Ministry of Health Ankara City Hospital, Pediatric Infectious Diseases Clinic, Ankara, Turkey
Phase 2b Booster Vaccination (TURKOVAC) Against COVID-19
- Conditions
- COVID-19Sars-CoV-2 Infection
- Interventions
- Biological: TURKOVAC-DollvetBiological: TURKOVAC-Koçak
- First Posted Date
- 2022-01-27
- Last Posted Date
- 2023-11-29
- Lead Sponsor
- Health Institutes of Turkey
- Target Recruit Count
- 65
- Registration Number
- NCT05210179
- Locations
- 🇹🇷
T.R. Ministry of Health Ankara City Hospital, Infectious Diseases and Clinical Microbiology Clinic, Ankara, Turkey
🇹🇷University of Health Sciences, Antalya Training and Research Hospital, Family Medicine Clinic, Antalya, Turkey
🇹🇷Abant İzzet Baysal University Izzet Baysal Training and Research Hospital, Bolu, Turkey
Phase 3 Booster Vaccination Against COVID-19
- Conditions
- Sars-CoV-2 InfectionCOVID-19
- Interventions
- Biological: CoronaVacBiological: Turkovac
- First Posted Date
- 2021-10-14
- Last Posted Date
- 2024-02-29
- Lead Sponsor
- Health Institutes of Turkey
- Target Recruit Count
- 4340
- Registration Number
- NCT05077176
- Locations
- 🇹🇷
T.R. Ministry of Health Ankara Keçiören Sanatorium Ataturk Chest Diseases and Thoracic Surgery Training and Research Hospital, Ankara, Turkey Region, Turkey
🇹🇷Çukurova University Faculty of Medicine, Department of Infectious Diseases, Adana, Turkey
🇹🇷T.R. Ministry of Health Ankara City Hospital, Infectious Diseases and Clinical Microbiology Clinic, Ankara, Turkey
Evaluation of the Efficacy, Safety and Immunogenicity of Inactivated COVID 19 Vaccine(TURKOVAC) in Healthy Population of 18 and 64 Years of Age (Both Inclusive):a Randomized, Double-blind, Phase IIb Clinical Trial
- Conditions
- Covid19
- Interventions
- Biological: Triple dose vaccination by inactivated Covid19 vaccine
- First Posted Date
- 2021-09-05
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- Health Institutes of Turkey
- Target Recruit Count
- 200
- Registration Number
- NCT05035238
- Locations
- 🇹🇷
Erciyes University Hakan Çetinsaya Iyi Klinik Uygulama ve Arastirma Merkezi, IKUM (Center for GCP), Kayseri, Turkey
Clinical Trial For Early SARS-CoV-2 (COVID-19) Treatment
- Conditions
- Covid19
- Interventions
- First Posted Date
- 2021-07-29
- Last Posted Date
- 2021-07-29
- Lead Sponsor
- Health Institutes of Turkey
- Target Recruit Count
- 1120
- Registration Number
- NCT04981379
- Locations
- 🇹🇷
Ankara City Hospital, Ankara, Turkey
🇹🇷Başakşehir Çam ve Sakura City Hospital, Istanbul, Turkey
🇹🇷Istanbul Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey
Booster Vaccination Against COVID-19
- Conditions
- Sars-CoV-2 InfectionCOVID-19
- Interventions
- Biological: TurkovacBiological: CoronaVac
- First Posted Date
- 2021-07-28
- Last Posted Date
- 2023-11-29
- Lead Sponsor
- Health Institutes of Turkey
- Target Recruit Count
- 222
- Registration Number
- NCT04979949
- Locations
- 🇹🇷
Ankara City Hospital Internal Medicine Clinic, Ankara, Turkey
🇹🇷Sancaktepe Martyr Professor Dr. İlhan Varank Training and Research Hospital Infectious Diseases and Clinical Microbiology Clinic, Istanbul, Turkey
🇹🇷T.R. Ministry of Health Kartal Dr. Lütfi Kirdar City Hospital Infectious Diseases, Istanbul, Turkey
Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine
- Conditions
- Covid19
- Interventions
- Biological: CoronaVacBiological: TURCOVAC
- First Posted Date
- 2021-06-28
- Last Posted Date
- 2024-02-29
- Lead Sponsor
- Health Institutes of Turkey
- Target Recruit Count
- 1290
- Registration Number
- NCT04942405
- Locations
- 🇹🇷
T.R. Ministry of Health Ankara City Hospital, Infectious Diseases and Clinical Microbiology Clinic, Ankara, Turkey Region, Turkey
🇹🇷Çukurova University Faculty of Medicine, Department of Infectious Diseases, Adana, Turkey
🇹🇷Hacettepe University Faculty of Medicine Department of Infections Diseases and Clinical Microbiology, Ankara, Turkey
Efficacy, Immunogenicity and Safety of Inactivated ERUCOV-VAC Compared With Placebo in COVID-19
- Conditions
- COVID-19
- Interventions
- Other: PlaceboBiological: ERUCOV-VAC 6 µg/0.5 ml VaccineBiological: ERUCOV-VAC 3 µg/0.5 ml Vaccine
- First Posted Date
- 2021-04-01
- Last Posted Date
- 2023-08-03
- Lead Sponsor
- Health Institutes of Turkey
- Target Recruit Count
- 250
- Registration Number
- NCT04824391
- Locations
- 🇹🇷
Erciyes University, Kayseri, Turkey